Agenus Inc (AGEN) stock
AGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$6.21−0.08 (-1.27%)
Close on Nov 17, 2026Market cap $279.58MP/E –Yield –
Agenus market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Agenus's market cap was $299.16M on Nov 10, 2026, against $149.63M a year earlier. Over the last 5 years it ranged from $7.90M to $6.86B, with a median of $103.04M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 10, 2026 | $299.16M | +190.3% |
| 2025 | Dec 31, 2025 | $103.04M | +73.4% |
| 2024 | Dec 31, 2024 | $59.42M | +337.7% |
| 2023 | Jan 31, 2023 | $13.58M | +8.8% |
| 2022 | Dec 30, 2022 | $12.48M | -10.1% |
| 2021 | Dec 31, 2021 | $13.89M | -99.8% |
| 2018 | Jan 31, 2018 | $6.86B | +10.7% |
| 2017 | Dec 29, 2017 | $6.19B | -13.1% |
| 2016 | Dec 30, 2016 | $7.13B | +8.1% |
| 2015 | Dec 31, 2015 | $6.59B | – |
See a number that looks wrong?